![One Meal a Day (OMAD) and your Health. [Study 18, 144-146 Analysis]](https://wm-img.halpindev.com/p-briefread_c-10_b-10/urlb/aHR0cDovL2ltZy55b3V0dWJlLmNvbS92aS9KS3dDOHNIRUVqWS9tYXhyZXNkZWZhdWx0LmpwZw==.jpg)
TLDR;
This video discusses the effects of One Meal A Day (OMAD), a form of intermittent fasting, on various health parameters, including blood pressure, blood sugar, and cholesterol. It analyses several studies and presents findings on metabolism, weight loss, and hormonal changes in participants.
- OMAD can lead to unintentional weight loss even without calorie counting.
- The effects on cholesterol and blood sugar tolerance may vary across studies; more research is required for conclusive results.
Introduction [0:00]
The presenter, Nicholas Verhoeven, introduces the topic of OMAD, highlighting its popularity as an extreme form of intermittent fasting. He explains that OMAD involves consuming one meal per day, generally after fasting for 20 to 23 hours. The video will cover four studies to evaluate the impact of OMAD on health metrics such as blood pressure, blood sugar, and cholesterol levels.
All Topics Covered [1:48]
Nicholas outlines the topics covered in the video, including the effects of OMAD on weight loss, inflammatory markers, and several hormone levels like leptin, ghrelin, and adiponectin. He mentions that the analysis is designed to be transparent, encouraging audience interaction and feedback.
Studies Analyzed [2:53]
Nicholas describes the studies included in the analysis, specifically studies 18, 144, 145, and 146. He acknowledges past delays in covering some studies on intermittent fasting and clarifies that future research on OMAD will also be discussed in upcoming videos.
Study 18 [4:03]
Study 18 involved 15 participants (primarily women) in a crossover design, comparing one meal a day with three meals a day for eight weeks each. Participants underwent a washout period of 11 weeks between the two dietary conditions. Blood measurements were taken after participants had fasted for varying durations, which brought up a significant consideration regarding timing and the impact on results.
Big Caveat of Note! [7:25]
Nicholas discusses a major caveat regarding the study design, particularly the timing of blood measurements. He highlights the potential issues of measuring blood parameters at different times of day, which could impact the validity of the results. The comparison of fasting periods between the OMAD and three meals a day conditions could lead to skewed data.
Study 18 Baseline Data [12:11]
The baseline data for study 18 reveals that participants had an average age of 45 years and some had slightly elevated LDL cholesterol levels. The nutritional intake for both dietary conditions was designed to be equivalent to maintain the participants' weights during the study.
Blood Pressure, Body Fat [19:00]
Nicholas presents findings on blood pressure and body fat from study 18. He reports a slight increase in systolic blood pressure for the OMAD group and some minor weight loss, which could be influenced by a small caloric deficit noted in the findings.
Blood Sugar, Cholesterol, Triglycerides, etc. [21:48]
Results from study 18 suggest an increase in total cholesterol and LDL levels for participants on the OMAD diet. Nicholas points out that HDL levels increased modestly, but overall findings on blood sugar levels are mixed. Triglycerides show no significant differences, indicating more extensive examination is needed for a conclusive understanding of these markers.
Study 144 [29:07]
Study 144 involves 15 people undergoing similar dietary conditions as study 18 but includes additional measurements through an Oral Glucose Tolerance Test (OGTT). This study aims to provide a deeper understanding of how OMAD impacts blood sugar tolerance and insulin sensitivity.
Glucose Tolerance [29:57]
In the analysis of glucose tolerance from study 144, participants showed less tolerance to blood sugar following OMAD, indicating potential insulin insensitivity, even though insulin levels remained unchanged. This demonstrates an aspect of metabolic performance that could shift with dietary timing.
Insulin Sensitivity & Hormones [33:04]
Nicholas covers various insulin sensitivity measures and hormones in study 144. Results indicate differences in insulin response during initial phases, with some hormones displaying no significant variation, reaffirming the complexity of how OMAD interacts with metabolic hormones.
Study 145 [38:40]
Study 145 features a smaller group (13 participants) and examines the effects of OMAD over 11 days, followed by a washout period. Similarities to earlier studies are acknowledged, noting particular results regarding weight loss and maintaining dietary guidelines.
Body Fat, Metabolism, and Blood Markers [40:33]
In this section, Nicholas elaborates on body composition changes, indicating a reduction in body fat and overall weight alongside stable resting metabolic rates, with an intriguing finding of elevated LDL cholesterol levels in the OMAD condition.
Blood Sugar throughout the Day [44:31]
Analysis of daily blood sugar levels indicates that participants experience similar average glucose levels regardless of meal timing, although there are fluctuations based on dietary patterns and timings.
Mixed Meal Test [46:50]
The mixed meal test evaluates glucose levels and insulin responses with a mixed meal including fats and proteins, revealing no definitive differences between the OMAD and traditional meal patterns.
Study 146 [50:16]
In study 146, the focus shifts to individuals with a slightly different demographic, examining the same factors with new findings. The study adds to the comprehensive analysis of OMAD's effects across various populations.
Individual Weight Loss & Diet Adherence [53:04]
Nicholas discusses how adherence to OMAD can vary significantly among participants, highlighting that successful results stem not just from dietary constraints but also from personal behaviours and lifestyle adherence.
Body Composition, Blood Sugar, Insulin with Weight Loss [58:14]
The final segment ties together body composition results with blood sugar data during weight loss phases, focusing on how OMAD can elicit weight loss, yet may influence blood markers such as cholesterol negatively.
Conclusions/Take Aways [1:02:05]
Nicholas concludes by summarising the findings, reinforcing that while OMAD might support unintended weight loss, it may have adverse effects on cholesterol levels and blood pressure compared to traditional meal patterns. Caution is advised, and further studies are necessary for clearer insights into long-term health effects.
